Tirzepatide – 20mg (3 Pack)

Tirzepatide is a dual incretin peptide that activates both GLP-1 (glucagon-like peptide-1)
and GIP (glucose-dependent insulinotropic polypeptide) receptors.
This dual-agonist mechanism has made it one of the most studied compounds in research
on obesity, insulin sensitivity, and metabolic regulation.
The 3 pack of 20mg vials delivers a total of 60mg for extended or multi-study use.

Potential Research Benefits

• Studied for weight management & appetite regulation
• Explored for insulin sensitivity & glycemic control
• Supports lipid metabolism & energy balance
• Dual receptor activity: GLP-1 & GIP

Scientific Background

By engaging both GLP-1 and GIP receptors, Tirzepatide may deliver enhanced
metabolic effects compared to single-agonist peptides.
Research suggests improvements in weight reduction, appetite regulation,
and glycemic stability, making it a leading candidate in experimental studies
focused on obesity and type 2 diabetes.

Product Details

• Compound: Tirzepatide
• Form: Lyophilized Powder
• Amount: 20mg per vial
• Pack Size: 3 vials (20mg each)
• Total Peptide: 60mg
• Purity: ≥99%
• Appearance: White to off-white powder
• Research Use Only: Not for human consumption